Concierge medicine
Member-facing cognitive performance baselining and repeat measurement.
Product · in development
RetinaTek's first planned commercial product brings objective, repeatable brain-performance measurement to concierge, executive, longevity, preventive health, and performance-focused clinical settings.
RT-Focus (Focused Objective Cognitive Utility System) is RetinaTek's first planned commercial product: a supervised cognitive performance assessment for executive medicine, concierge primary care, longevity, preventive health, cognitive-aging, and performance-focused workflows. RetinaTek is engaging FDA through the Q-submission process to confirm the appropriate regulatory pathway. RT-Focus is not positioned as a diagnostic disease test.
Premium care programs already measure heart health, metabolic health, sleep, hormones, imaging, fitness, and other biomarkers. Cognitive performance is often still under-measured.
RT-Focus is designed to translate RETINA's task-evoked measurement architecture into a brief, supervised, in-clinic cognitive performance assessment that trained clinical staff can administer in existing premium-care workflows.
Member-facing cognitive performance baselining and repeat measurement.
Objective brain-performance measurement for high-performing professionals.
Cognitive performance baselining and repeat measurement as part of broader healthspan programs.
A practical way to support repeat measurement of functional cognitive performance over time.
Repeat measurement for patients concerned about memory, focus, or cognitive change.
Brain-performance reporting for patients focused on readiness, focus, and optimization.
RT-Focus uses RetinaTek's task-evoked measurement architecture to capture cognitive performance during a brief, standardized assessment. The goal is to provide practical, repeatable outputs that help clinicians and members understand performance patterns over time.
How efficiently the participant responds to task-relevant information.
How consistently the participant manages attention, inhibition, and competing demands.
How stable performance remains across repeated task events.
How accurately the participant completes controlled cognitive challenges.
How performance trends across repeat assessments.
RT-Focus is designed to fit supervised premium-care workflows without requiring a full neuropsychological testing environment.
Designed for short, low-burden administration.
Can be run by trained clinical staff in supervised workflows.
Creates a controlled visual environment for task-evoked measurement.
Supports practical reporting for clinician and member discussion.
Designed for baselining and longitudinal follow-up.
Works alongside executive physicals, longevity visits, and preventive health programs.
Many patients want to know whether their cognitive performance is stable, improving, or changing over time. RT-Focus gives premium practices a practical way to offer supervised cognitive performance baselining and repeat measurement as part of longevity, preventive health, and executive medicine programs.
RT-Focus is RetinaTek's planned near-term commercial wedge. It may create revenue and real-world deployment experience while RetinaTek builds toward future regulated indications and broader platform markets.
Creates a claims-disciplined path to commercial activity before future disease-specific claims.
Reveals what works in administration, training, reporting, support, and repeat testing.
Builds operational experience with longitudinal cognitive performance measurement.
Improves report design, user experience, data flow, and service delivery.
Strengthens conversations with clinics, researchers, strategic partners, and investors.
Helps de-risk future regulated clinical-development work.
RT-Focus is a planned supervised cognitive performance assessment. It is not positioned as a diagnostic disease test. Disease-specific diagnostic or monitoring claims require appropriate validation and regulatory clearance.
RT-Focus is a planned supervised cognitive performance assessment and is not positioned as a diagnostic disease test. RetinaTek is engaging FDA through the Q-submission process to confirm the appropriate regulatory pathway. Disease-specific diagnostic or monitoring claims require appropriate validation and regulatory clearance.
RT-Focus is in development as RetinaTek's first planned commercial product for supervised cognitive performance assessment. Visit the RT-Focus product site for the latest product preview and launch updates.